Treatment and management of patients with end-stage liver cirrhosis
DOI:10.3969/j.issn.1001-5256.2021.01.007
- VernacularTitle:肝硬化终末期患者的治疗和管理
- Author:
Ming YANG
1
;
Yuan HUANG
;
Lai WEI
Author Information
1. Hepatobiliary and Pancreatic Center, Tsinghua University Affiliated Beijing Tsinghua Changgeng Hospital
- Publication Type:Research Article
- Keywords:
Liver Cirrhosis;
End Stage Liver Disease;
Liver, Artificial;
Therapeutics
- From:
Journal of Clinical Hepatology
2021;37(1):31-35
- CountryChina
- Language:Chinese
-
Abstract:
End-stage liver cirrhosis usually refers to chronic liver failure caused by decompensated liver cirrhosis and brings a heavy burden to human health. Liver transplantation is the most effective treatment, but its clinical application is limited by the shortage of liver source and high cost. Artificial liver support system is often used as bridging therapy to liver transplantation. The development of cell therapy brings new hope to this disease. This article summarizes the etiological treatment of end-stage liver cirrhosis and the management of related complications and introduces the indications and timing for artificial liver support system, cell therapy, and liver transplantation in patients with end-stage liver cirrhosis.
